| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Glycoconjugates | 4 | 2017 | 32 | 1.09 | Why? |
| Pneumonia, Pneumococcal | 6 | 2018 | 251 | 0.85 | Why? |
| Streptococcus pneumoniae | 10 | 2018 | 827 | 0.82 | Why? |
| Capillary Permeability | 2 | 2021 | 277 | 0.80 | Why? |
| Bacterial Vaccines | 1 | 2017 | 139 | 0.63 | Why? |
| Granuloma | 1 | 2017 | 88 | 0.61 | Why? |
| Carbapenems | 1 | 2017 | 343 | 0.54 | Why? |
| Klebsiella pneumoniae | 2 | 2017 | 658 | 0.48 | Why? |
| Community-Acquired Infections | 6 | 2021 | 2328 | 0.43 | Why? |
| Disease Models, Animal | 11 | 2021 | 10998 | 0.41 | Why? |
| Endothelial Cells | 4 | 2021 | 2048 | 0.37 | Why? |
| Oligosaccharides | 2 | 2017 | 69 | 0.34 | Why? |
| Pneumonia, Bacterial | 3 | 2019 | 843 | 0.33 | Why? |
| Anti-Bacterial Agents | 7 | 2019 | 10083 | 0.32 | Why? |
| Peptide Fragments | 1 | 2017 | 2075 | 0.32 | Why? |
| Vaccines, Synthetic | 2 | 2017 | 3231 | 0.30 | Why? |
| Antibodies, Bacterial | 3 | 2017 | 510 | 0.29 | Why? |
| Lung | 12 | 2021 | 31049 | 0.27 | Why? |
| Mice, Inbred C57BL | 10 | 2020 | 5542 | 0.27 | Why? |
| Chemokine CCL3 | 2 | 2020 | 103 | 0.26 | Why? |
| Pneumococcal Vaccines | 3 | 2017 | 571 | 0.25 | Why? |
| Pneumonia | 5 | 2021 | 5652 | 0.25 | Why? |
| Lung Diseases | 1 | 2017 | 2361 | 0.25 | Why? |
| Respiratory Tract Infections | 2 | 2021 | 6817 | 0.24 | Why? |
| Rabbits | 4 | 2017 | 1171 | 0.23 | Why? |
| Communicable Diseases | 1 | 2017 | 2148 | 0.23 | Why? |
| Membrane Potential, Mitochondrial | 2 | 2018 | 102 | 0.23 | Why? |
| Alveolar Epithelial Cells | 2 | 2021 | 1445 | 0.22 | Why? |
| Mice | 14 | 2020 | 21357 | 0.22 | Why? |
| Pneumococcal Infections | 2 | 2018 | 562 | 0.22 | Why? |
| Receptors, CCR1 | 1 | 2020 | 49 | 0.22 | Why? |
| Chemokine CCL4 | 1 | 2020 | 71 | 0.21 | Why? |
| Mitochondria | 2 | 2018 | 857 | 0.21 | Why? |
| Silicones | 1 | 2019 | 26 | 0.21 | Why? |
| Inflammation | 9 | 2021 | 13255 | 0.20 | Why? |
| Sialic Acid Binding Ig-like Lectin 1 | 1 | 2021 | 156 | 0.20 | Why? |
| Myelopoiesis | 1 | 2020 | 116 | 0.20 | Why? |
| Cystathionine gamma-Lyase | 1 | 2018 | 4 | 0.19 | Why? |
| Angiopoietin-1 | 1 | 2018 | 25 | 0.19 | Why? |
| Mitochondrial Dynamics | 1 | 2018 | 30 | 0.19 | Why? |
| Streptolysins | 1 | 2018 | 8 | 0.19 | Why? |
| Receptors, Lysosphingolipid | 1 | 2018 | 25 | 0.19 | Why? |
| Phagocytosis | 2 | 2017 | 409 | 0.19 | Why? |
| Electric Impedance | 1 | 2021 | 283 | 0.18 | Why? |
| IgA Deficiency | 1 | 2018 | 36 | 0.18 | Why? |
| Monocytes | 2 | 2021 | 2978 | 0.18 | Why? |
| Toll-Like Receptors | 1 | 2021 | 365 | 0.18 | Why? |
| Cytochrome b Group | 1 | 2017 | 8 | 0.18 | Why? |
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2018 | 49 | 0.18 | Why? |
| Vaccines, Conjugate | 2 | 2017 | 328 | 0.18 | Why? |
| Praziquantel | 1 | 2017 | 44 | 0.17 | Why? |
| Serogroup | 2 | 2017 | 510 | 0.17 | Why? |
| Cytological Techniques | 1 | 2018 | 79 | 0.17 | Why? |
| Statistics, Nonparametric | 2 | 2018 | 1008 | 0.17 | Why? |
| Nucleotidyltransferases | 1 | 2018 | 77 | 0.17 | Why? |
| Eicosapentaenoic Acid | 1 | 2018 | 106 | 0.17 | Why? |
| beta-Lactams | 1 | 2019 | 210 | 0.17 | Why? |
| Endothelium | 1 | 2021 | 460 | 0.17 | Why? |
| Angiopoietin-2 | 1 | 2018 | 125 | 0.17 | Why? |
| NADPH Oxidases | 1 | 2017 | 80 | 0.17 | Why? |
| Spectrometry, Fluorescence | 1 | 2017 | 177 | 0.17 | Why? |
| Hydrogen Sulfide | 1 | 2018 | 86 | 0.17 | Why? |
| T-Lymphocytes, Cytotoxic | 1 | 2021 | 552 | 0.17 | Why? |
| Coronavirus NL63, Human | 2 | 2020 | 669 | 0.16 | Why? |
| Animals | 19 | 2021 | 78931 | 0.16 | Why? |
| Schistosomiasis | 1 | 2017 | 59 | 0.16 | Why? |
| Cricetinae | 2 | 2021 | 3344 | 0.16 | Why? |
| Proteoglycans | 1 | 2017 | 130 | 0.16 | Why? |
| Anthelmintics | 1 | 2017 | 104 | 0.16 | Why? |
| DNA, Mitochondrial | 1 | 2018 | 163 | 0.16 | Why? |
| Blood Proteins | 1 | 2020 | 551 | 0.16 | Why? |
| Macrolides | 1 | 2019 | 369 | 0.16 | Why? |
| Complement C1 Inhibitor Protein | 1 | 2017 | 124 | 0.15 | Why? |
| Pulmonary Emphysema | 1 | 2017 | 122 | 0.15 | Why? |
| Pulmonary Alveoli | 1 | 2021 | 867 | 0.15 | Why? |
| Mesocricetus | 1 | 2021 | 1847 | 0.15 | Why? |
| Vasodilation | 1 | 2018 | 258 | 0.15 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2019 | 12361 | 0.15 | Why? |
| Single-Cell Analysis | 3 | 2020 | 2450 | 0.15 | Why? |
| Ventilator-Induced Lung Injury | 1 | 2018 | 260 | 0.15 | Why? |
| Myeloid Cells | 1 | 2020 | 808 | 0.14 | Why? |
| Proteomics | 3 | 2021 | 2481 | 0.14 | Why? |
| Ventilator Weaning | 1 | 2020 | 536 | 0.14 | Why? |
| Coronavirus OC43, Human | 2 | 2020 | 1157 | 0.14 | Why? |
| Histones | 1 | 2017 | 371 | 0.14 | Why? |
| Coronavirus 229E, Human | 2 | 2020 | 1241 | 0.14 | Why? |
| Cardiotoxicity | 1 | 2017 | 365 | 0.13 | Why? |
| Proteome | 2 | 2021 | 1812 | 0.13 | Why? |
| Pseudomonas Infections | 1 | 2018 | 425 | 0.13 | Why? |
| Respiratory System | 3 | 2021 | 3213 | 0.13 | Why? |
| Pseudomonas aeruginosa | 1 | 2018 | 652 | 0.13 | Why? |
| Host Specificity | 1 | 2017 | 926 | 0.12 | Why? |
| Klebsiella Infections | 1 | 2017 | 466 | 0.12 | Why? |
| Neoplasm Proteins | 1 | 2017 | 501 | 0.12 | Why? |
| Macrophages | 2 | 2021 | 2784 | 0.11 | Why? |
| Hyperglycemia | 2 | 2019 | 1363 | 0.11 | Why? |
| Image Interpretation, Computer-Assisted | 1 | 2018 | 665 | 0.11 | Why? |
| Coronavirus | 2 | 2020 | 18339 | 0.11 | Why? |
| Nitric Oxide | 1 | 2018 | 769 | 0.11 | Why? |
| Plasma | 1 | 2021 | 1809 | 0.11 | Why? |
| Orthomyxoviridae Infections | 1 | 2018 | 1001 | 0.11 | Why? |
| Immunoglobulin A | 2 | 2021 | 3567 | 0.10 | Why? |
| Germany | 6 | 2021 | 9196 | 0.10 | Why? |
| Dexamethasone | 1 | 2021 | 2055 | 0.10 | Why? |
| Berlin | 2 | 2020 | 283 | 0.10 | Why? |
| Coronavirus Infections | 9 | 2020 | 253789 | 0.10 | Why? |
| Hypertension | 3 | 2021 | 8895 | 0.10 | Why? |
| Acute Lung Injury | 1 | 2018 | 904 | 0.10 | Why? |
| Humans | 41 | 2021 | 930598 | 0.10 | Why? |
| Mice, Knockout | 3 | 2018 | 1815 | 0.09 | Why? |
| Kinetics | 3 | 2021 | 3238 | 0.09 | Why? |
| Microbiota | 1 | 2018 | 1240 | 0.09 | Why? |
| Blood Glucose | 2 | 2019 | 3642 | 0.09 | Why? |
| Lung Injury | 1 | 2017 | 919 | 0.09 | Why? |
| Hypertension, Pulmonary | 1 | 2017 | 970 | 0.09 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2018 | 2483 | 0.09 | Why? |
| Drug Resistance, Bacterial | 1 | 2017 | 1414 | 0.09 | Why? |
| Biomarkers | 3 | 2021 | 23361 | 0.09 | Why? |
| Pneumonia, Viral | 10 | 2020 | 243684 | 0.09 | Why? |
| Membrane Proteins | 1 | 2018 | 1733 | 0.08 | Why? |
| Blood Donors | 1 | 2021 | 2956 | 0.08 | Why? |
| Transcriptome | 1 | 2020 | 3466 | 0.08 | Why? |
| Machine Learning | 2 | 2021 | 4395 | 0.08 | Why? |
| Blood Pressure | 1 | 2018 | 2198 | 0.08 | Why? |
| Prospective Studies | 9 | 2021 | 43301 | 0.08 | Why? |
| Blood Gas Analysis | 2 | 2021 | 893 | 0.08 | Why? |
| Female | 25 | 2021 | 380317 | 0.08 | Why? |
| Bronchoalveolar Lavage Fluid | 3 | 2020 | 2309 | 0.07 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.07 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2018 | 7868 | 0.07 | Why? |
| Myocardium | 1 | 2017 | 2323 | 0.07 | Why? |
| Disease Progression | 2 | 2021 | 13580 | 0.07 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2020 | 4545 | 0.07 | Why? |
| Signal Transduction | 1 | 2021 | 7207 | 0.07 | Why? |
| Austria | 2 | 2019 | 1259 | 0.07 | Why? |
| Time Factors | 4 | 2021 | 31397 | 0.07 | Why? |
| Antibodies, Viral | 3 | 2021 | 51949 | 0.07 | Why? |
| Antibodies, Monoclonal | 2 | 2020 | 8041 | 0.07 | Why? |
| Immunoglobulin M | 1 | 2021 | 9091 | 0.07 | Why? |
| Evidence-Based Medicine | 1 | 2017 | 3228 | 0.06 | Why? |
| Middle Aged | 18 | 2021 | 270681 | 0.06 | Why? |
| Diagnosis, Differential | 1 | 2017 | 7220 | 0.06 | Why? |
| Aged | 15 | 2021 | 215776 | 0.06 | Why? |
| Occludin | 1 | 2021 | 53 | 0.06 | Why? |
| Adult | 16 | 2021 | 244371 | 0.06 | Why? |
| Cytokines | 2 | 2021 | 15010 | 0.06 | Why? |
| Lung Neoplasms | 1 | 2018 | 3228 | 0.06 | Why? |
| CD11 Antigens | 1 | 2020 | 74 | 0.05 | Why? |
| Respiration, Artificial | 4 | 2021 | 22116 | 0.05 | Why? |
| Actins | 1 | 2021 | 108 | 0.05 | Why? |
| Male | 19 | 2021 | 367725 | 0.05 | Why? |
| Respiratory Insufficiency | 2 | 2019 | 7301 | 0.05 | Why? |
| Cadherins | 1 | 2021 | 145 | 0.05 | Why? |
| Algorithms | 1 | 2018 | 7346 | 0.05 | Why? |
| Propensity Score | 2 | 2019 | 2690 | 0.05 | Why? |
| Neutrophils | 1 | 2017 | 5476 | 0.05 | Why? |
| Registries | 1 | 2020 | 12327 | 0.05 | Why? |
| Sepsis | 1 | 2017 | 3517 | 0.05 | Why? |
| Enzyme Activation | 1 | 2021 | 425 | 0.05 | Why? |
| Heart Failure | 1 | 2021 | 6638 | 0.05 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 3832 | 0.05 | Why? |
| Cell Respiration | 1 | 2018 | 26 | 0.05 | Why? |
| Mesenteric Arteries | 1 | 2018 | 22 | 0.05 | Why? |
| Ampicillin | 1 | 2018 | 73 | 0.05 | Why? |
| Antigen-Antibody Reactions | 1 | 2020 | 616 | 0.05 | Why? |
| Pandemics | 9 | 2021 | 389249 | 0.05 | Why? |
| Arachidonic Acid | 1 | 2018 | 90 | 0.04 | Why? |
| Calcimycin | 1 | 2017 | 6 | 0.04 | Why? |
| omega-N-Methylarginine | 1 | 2017 | 5 | 0.04 | Why? |
| Respiratory Burst | 1 | 2017 | 16 | 0.04 | Why? |
| Azepines | 1 | 2017 | 17 | 0.04 | Why? |
| Severity of Illness Index | 6 | 2021 | 48226 | 0.04 | Why? |
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 2017 | 15 | 0.04 | Why? |
| Cell Communication | 1 | 2020 | 396 | 0.04 | Why? |
| HLA-DR Antigens | 1 | 2020 | 563 | 0.04 | Why? |
| Host-Pathogen Interactions | 1 | 2018 | 11041 | 0.04 | Why? |
| Polysaccharides, Bacterial | 1 | 2017 | 59 | 0.04 | Why? |
| Cells, Cultured | 2 | 2020 | 5835 | 0.04 | Why? |
| HL-60 Cells | 1 | 2017 | 60 | 0.04 | Why? |
| Pancreatic Elastase | 1 | 2017 | 41 | 0.04 | Why? |
| Fatty Acid-Binding Proteins | 1 | 2017 | 93 | 0.04 | Why? |
| Bacterial Capsules | 1 | 2017 | 39 | 0.04 | Why? |
| Pattern Recognition, Automated | 1 | 2018 | 160 | 0.04 | Why? |
| Papio | 1 | 2017 | 104 | 0.04 | Why? |
| Bacterial Load | 1 | 2017 | 179 | 0.04 | Why? |
| Stress, Mechanical | 1 | 2017 | 143 | 0.04 | Why? |
| Glycomics | 1 | 2017 | 61 | 0.04 | Why? |
| Vascular Remodeling | 1 | 2017 | 99 | 0.04 | Why? |
| Biological Availability | 1 | 2018 | 388 | 0.04 | Why? |
| Antibodies, Neutralizing | 2 | 2021 | 25288 | 0.04 | Why? |
| Frameshift Mutation | 1 | 2017 | 158 | 0.04 | Why? |
| Primary Cell Culture | 1 | 2018 | 501 | 0.04 | Why? |
| Docosahexaenoic Acids | 1 | 2018 | 145 | 0.04 | Why? |
| Blood | 1 | 2017 | 274 | 0.04 | Why? |
| Microvessels | 1 | 2021 | 490 | 0.04 | Why? |
| Mice, Inbred BALB C | 2 | 2017 | 5814 | 0.04 | Why? |
| Legionella pneumophila | 1 | 2017 | 143 | 0.04 | Why? |
| Chemokine CCL2 | 1 | 2018 | 389 | 0.04 | Why? |
| Carbon Monoxide | 1 | 2017 | 167 | 0.04 | Why? |
| Vasoconstriction | 1 | 2017 | 153 | 0.04 | Why? |
| Intensive Care Units | 2 | 2020 | 29594 | 0.04 | Why? |
| Prognosis | 4 | 2021 | 32490 | 0.04 | Why? |
| Bronchoalveolar Lavage | 1 | 2019 | 603 | 0.04 | Why? |
| Influenza A virus | 2 | 2018 | 2234 | 0.04 | Why? |
| Iatrogenic Disease | 1 | 2018 | 304 | 0.04 | Why? |
| Mitochondrial Membrane Transport Proteins | 1 | 2018 | 239 | 0.04 | Why? |
| Antigens, CD | 1 | 2021 | 984 | 0.04 | Why? |
| Practice Guidelines as Topic | 1 | 2020 | 15421 | 0.04 | Why? |
| Blood Cell Count | 1 | 2021 | 1101 | 0.04 | Why? |
| Echocardiography | 2 | 2021 | 3661 | 0.04 | Why? |
| Diabetes Mellitus | 1 | 2017 | 8207 | 0.04 | Why? |
| Adenosine Triphosphate | 1 | 2018 | 294 | 0.04 | Why? |
| Analysis of Variance | 1 | 2018 | 950 | 0.04 | Why? |
| Blotting, Western | 1 | 2017 | 863 | 0.04 | Why? |
| Automation, Laboratory | 1 | 2018 | 536 | 0.04 | Why? |
| Longitudinal Studies | 2 | 2021 | 9893 | 0.04 | Why? |
| Hospitalization | 6 | 2021 | 54280 | 0.04 | Why? |
| Healthy Volunteers | 1 | 2020 | 1444 | 0.03 | Why? |
| Young Adult | 6 | 2021 | 93724 | 0.03 | Why? |
| Acinetobacter baumannii | 1 | 2017 | 378 | 0.03 | Why? |
| Cell Differentiation | 1 | 2020 | 1338 | 0.03 | Why? |
| Ventricular Function, Right | 1 | 2017 | 388 | 0.03 | Why? |
| Predictive Value of Tests | 2 | 2019 | 9537 | 0.03 | Why? |
| Species Specificity | 1 | 2017 | 1356 | 0.03 | Why? |
| Disease-Free Survival | 1 | 2018 | 1654 | 0.03 | Why? |
| Caco-2 Cells | 1 | 2017 | 1236 | 0.03 | Why? |
| Administration, Intranasal | 1 | 2017 | 1132 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2020 | 37182 | 0.03 | Why? |
| Crystallography, X-Ray | 1 | 2020 | 2689 | 0.03 | Why? |
| Up-Regulation | 1 | 2021 | 2249 | 0.03 | Why? |
| Data Interpretation, Statistical | 1 | 2017 | 657 | 0.03 | Why? |
| History, 21st Century | 1 | 2020 | 1849 | 0.03 | Why? |
| Triazoles | 1 | 2017 | 440 | 0.03 | Why? |
| Prevalence | 3 | 2021 | 25773 | 0.03 | Why? |
| Calcium | 1 | 2018 | 708 | 0.03 | Why? |
| Observational Studies as Topic | 1 | 2020 | 1887 | 0.03 | Why? |
| Africa South of the Sahara | 1 | 2017 | 1335 | 0.03 | Why? |
| Aged, 80 and over | 5 | 2020 | 88759 | 0.03 | Why? |
| Interleukin-8 | 1 | 2018 | 964 | 0.03 | Why? |
| Biological Specimen Banks | 1 | 2020 | 1142 | 0.03 | Why? |
| Ventricular Function, Left | 1 | 2021 | 1555 | 0.03 | Why? |
| Reactive Oxygen Species | 1 | 2018 | 1136 | 0.03 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2020 | 1439 | 0.03 | Why? |
| Troponin T | 1 | 2017 | 771 | 0.03 | Why? |
| Cohort Studies | 3 | 2021 | 36005 | 0.03 | Why? |
| Europe | 2 | 2019 | 12702 | 0.03 | Why? |
| Adenocarcinoma | 1 | 2018 | 651 | 0.03 | Why? |
| Stroke Volume | 1 | 2021 | 2153 | 0.03 | Why? |
| Seroconversion | 1 | 2021 | 2515 | 0.03 | Why? |
| Staphylococcus aureus | 1 | 2017 | 844 | 0.03 | Why? |
| Bacteria | 1 | 2021 | 1897 | 0.03 | Why? |
| Anti-Inflammatory Agents | 2 | 2021 | 6153 | 0.03 | Why? |
| Risk Factors | 4 | 2021 | 71621 | 0.03 | Why? |
| Immune System | 1 | 2020 | 1479 | 0.03 | Why? |
| Lymphocyte Activation | 1 | 2020 | 2742 | 0.03 | Why? |
| Viral Load | 2 | 2021 | 15850 | 0.03 | Why? |
| Case-Control Studies | 2 | 2021 | 17671 | 0.03 | Why? |
| Immunohistochemistry | 1 | 2017 | 2275 | 0.03 | Why? |
| Escherichia coli | 1 | 2017 | 1547 | 0.03 | Why? |
| Age Factors | 2 | 2021 | 21039 | 0.02 | Why? |
| Convalescence | 1 | 2021 | 2829 | 0.02 | Why? |
| Interleukin-6 | 2 | 2018 | 7522 | 0.02 | Why? |
| Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 896 | 0.02 | Why? |
| Polysaccharides | 1 | 2017 | 854 | 0.02 | Why? |
| Epitopes, T-Lymphocyte | 1 | 2020 | 2262 | 0.02 | Why? |
| Phenotype | 1 | 2020 | 4037 | 0.02 | Why? |
| Peptidyl-Dipeptidase A | 2 | 2020 | 9659 | 0.02 | Why? |
| Cell Line, Tumor | 1 | 2018 | 3608 | 0.02 | Why? |
| Aspirin | 1 | 2017 | 1043 | 0.02 | Why? |
| Bacterial Proteins | 1 | 2018 | 1318 | 0.02 | Why? |
| Treatment Outcome | 3 | 2020 | 51732 | 0.02 | Why? |
| Cross Reactions | 1 | 2020 | 4374 | 0.02 | Why? |
| Leukocytes, Mononuclear | 1 | 2018 | 2115 | 0.02 | Why? |
| Viruses | 1 | 2021 | 2238 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2020 | 4020 | 0.02 | Why? |
| Epithelial Cells | 1 | 2020 | 3508 | 0.02 | Why? |
| Binding Sites | 1 | 2020 | 6201 | 0.02 | Why? |
| Heart | 1 | 2017 | 1791 | 0.02 | Why? |
| Molecular Dynamics Simulation | 1 | 2020 | 4155 | 0.02 | Why? |
| World Health Organization | 1 | 2020 | 4213 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2019 | 6543 | 0.02 | Why? |
| Software | 1 | 2018 | 2501 | 0.02 | Why? |
| Odds Ratio | 1 | 2017 | 5861 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2019 | 7268 | 0.02 | Why? |
| Acute Disease | 1 | 2018 | 6029 | 0.02 | Why? |
| Survival Analysis | 1 | 2018 | 7592 | 0.02 | Why? |
| Transients and Migrants | 1 | 2017 | 1468 | 0.02 | Why? |
| Cell Line | 1 | 2020 | 12040 | 0.02 | Why? |
| Interferon Type I | 1 | 2018 | 2789 | 0.02 | Why? |
| Immunization, Passive | 1 | 2021 | 10067 | 0.02 | Why? |
| Virus Shedding | 1 | 2021 | 5834 | 0.02 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2020 | 3892 | 0.02 | Why? |
| Protein Binding | 1 | 2020 | 11430 | 0.02 | Why? |
| Fever | 1 | 2021 | 7795 | 0.02 | Why? |
| Sex Factors | 1 | 2021 | 11014 | 0.02 | Why? |
| Tertiary Care Centers | 1 | 2021 | 8248 | 0.02 | Why? |
| Electrocardiography | 1 | 2017 | 3957 | 0.02 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.02 | Why? |
| B-Lymphocytes | 1 | 2017 | 4418 | 0.02 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.02 | Why? |
| Hypoxia | 1 | 2017 | 3626 | 0.01 | Why? |
| Adrenal Cortex Hormones | 1 | 2019 | 6537 | 0.01 | Why? |
| Disease Management | 1 | 2020 | 6841 | 0.01 | Why? |
| Nasopharynx | 1 | 2020 | 10224 | 0.01 | Why? |
| Models, Biological | 1 | 2018 | 4907 | 0.01 | Why? |
| T-Lymphocytes | 1 | 2017 | 6670 | 0.01 | Why? |
| Immunity, Innate | 1 | 2018 | 6570 | 0.01 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.01 | Why? |
| Travel | 1 | 2017 | 7220 | 0.01 | Why? |
| Retrospective Studies | 2 | 2021 | 105322 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.01 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
| Infant, Newborn | 1 | 2017 | 23105 | 0.01 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2017 | 8843 | 0.01 | Why? |
| Hospital Mortality | 1 | 2019 | 22087 | 0.01 | Why? |
| Comorbidity | 1 | 2019 | 34796 | 0.01 | Why? |
| Infant | 1 | 2017 | 30274 | 0.01 | Why? |
| Critical Care | 1 | 2017 | 14081 | 0.01 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.01 | Why? |
| Child, Preschool | 1 | 2017 | 36283 | 0.01 | Why? |
| Vaccination | 1 | 2017 | 19050 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.01 | Why? |
| Child | 1 | 2017 | 70012 | 0.01 | Why? |